Established in 2006, Polgenix, Inc. is a small biotech company located in Cleveland, Ohio whose aim is to solve structures of G protein-coupled receptors (GPCRs) for drug discovery purposes using a unique protein expression system.
Richard Sutkus, Ph.D., CEO
Krzysztof Palczewski, Ph.D., Chief Scientific Officer
Vida M. Tripodo, Director of Finance & Administration
Grazyna Palczewska, M.Sc., M.E., Director of Medical Device Development
David Salom, Ph.D., Scientist
Wenyu Sun, Ph.D., Scientist
Zhiqian Dong, M.D., Ph.D., Research Scientist